Literature DB >> 18306242

Lesion distribution in children with clinically isolated syndromes.

Rezwan Ghassemi1, Samson B Antel, Sridar Narayanan, Simon J Francis, Amit Bar-Or, A Dessa Sadovnick, Brenda Banwell, Douglas L Arnold.   

Abstract

We evaluated the incidence, volume, and spatial distribution of T2-weighted magnetic resonance imaging lesions in 58 children with clinically isolated syndromes at risk for multiple sclerosis compared with 58 adults with relapsing-remitting multiple sclerosis. Pediatric patients with clinically isolated syndromes who had brain lesions had supratentorial lesion volumes similar to adult multiple sclerosis patients, but greater infratentorial lesion volumes (p < 0.009), particularly in the pons of male patients. The predilection for infratentorial lesions the pediatric patients with clinically isolated syndromes may reflect immunological differences or differences in myelin, possibly related to the caudorostral temporal gradient in myelin maturation.

Entities:  

Mesh:

Year:  2008        PMID: 18306242     DOI: 10.1002/ana.21322

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

Authors:  Leonard H Verhey; Helen M Branson; Monica Makhija; Manohar Shroff; Brenda Banwell
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

Review 2.  Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Authors:  Sniya Valsa Sudhakar; Karthik Muthusamy; Sunithi Mani; Sridhar Gibikote; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

Review 3.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

4.  Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.

Authors:  Maria A Rocca; Paola Valsasina; Martina Absinta; Lucia Moiola; Angelo Ghezzi; Pierangelo Veggiotti; Maria P Amato; Mark A Horsfield; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

Review 5.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 6.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

7.  Pediatric multiple sclerosis.

Authors:  Emmanuelle Waubant; Dorothee Chabas
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

Review 8.  Pediatric multiple sclerosis.

Authors:  Dorothee Chabas; Jonathan Strober; Emmanuelle Waubant
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

9.  Magnetic resonance imaging differential diagnosis of brainstem lesions in children.

Authors:  Carlo Cosimo Quattrocchi; Yuri Errante; Maria Camilla Rossi Espagnet; Stefania Galassi; Sabino Walter Della Sala; Bruno Bernardi; Giuseppe Fariello; Daniela Longo
Journal:  World J Radiol       Date:  2016-01-28

10.  Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.

Authors:  Kerstin Bendfeldt; Jan Ole Blumhagen; Hanspeter Egger; Patrick Loetscher; Niklaus Denier; Pascal Kuster; Stefan Traud; Nicole Mueller-Lenke; Yvonne Naegelin; Achim Gass; Jochen Hirsch; Ludwig Kappos; Thomas E Nichols; Ernst-Wilhelm Radue; Stefan J Borgwardt
Journal:  Hum Brain Mapp       Date:  2010-10       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.